122 related articles for article (PubMed ID: 22157091)
41. Phospholipase D1 Inhibition Linked to Upregulation of ICAT Blocks Colorectal Cancer Growth Hyperactivated by Wnt/β-Catenin and PI3K/Akt Signaling.
Kang DW; Lee BH; Suh YA; Choi YS; Jang SJ; Kim YM; Choi KY; Min DS
Clin Cancer Res; 2017 Dec; 23(23):7340-7350. PubMed ID: 28939743
[No Abstract] [Full Text] [Related]
42. Scutellaria barbata D. Don inhibits colorectal cancer growth via suppression of Wnt/β-catenin signaling pathway.
Wei LH; Lin JM; Chu JF; Chen HW; Li QY; Peng J
Chin J Integr Med; 2017 Nov; 23(11):858-863. PubMed ID: 29080197
[TBL] [Abstract][Full Text] [Related]
43. The Discovery and Characterization of K-756, a Novel Wnt/β-Catenin Pathway Inhibitor Targeting Tankyrase.
Okada-Iwasaki R; Takahashi Y; Watanabe Y; Ishida H; Saito J; Nakai R; Asai A
Mol Cancer Ther; 2016 Jul; 15(7):1525-34. PubMed ID: 27196752
[TBL] [Abstract][Full Text] [Related]
44. [Abnormalities of chromosome 8, APC and beta-catenin genes in aggressive fibromatosis].
Yang JL; Wang J; Zhou XY; Zhu XZ
Zhonghua Zhong Liu Za Zhi; 2008 Feb; 30(2):116-20. PubMed ID: 18646694
[TBL] [Abstract][Full Text] [Related]
45. EphB/EphrinB receptors and Wnt signaling in colorectal cancer.
Clevers H; Batlle E
Cancer Res; 2006 Jan; 66(1):2-5. PubMed ID: 16397205
[TBL] [Abstract][Full Text] [Related]
46. Connecting COX-2 and Wnt in cancer.
Buchanan FG; DuBois RN
Cancer Cell; 2006 Jan; 9(1):6-8. PubMed ID: 16413466
[TBL] [Abstract][Full Text] [Related]
47. Hsa-miR-942 fingerprint in colorectal cancer through Wnt signaling pathway.
Fasihi A; Soltani BM; Ranjbaran ZS; Bahonar S; Norouzi R; Nasiri S
Gene; 2019 Sep; 712():143958. PubMed ID: 31278963
[TBL] [Abstract][Full Text] [Related]
48. Inhibitory effect of selenomethionine on carcinogenesis in the model of human colorectal cancer in vitro and its link to the Wnt/β-catenin pathway.
Korbut E; Ptak-Belowska A; Brzozowski T
Acta Biochim Pol; 2018; 65(3):359-366. PubMed ID: 30016378
[TBL] [Abstract][Full Text] [Related]
49. IWR-1 inhibits epithelial-mesenchymal transition of colorectal cancer cells through suppressing Wnt/β-catenin signaling as well as survivin expression.
Lee SC; Kim OH; Lee SK; Kim SJ
Oncotarget; 2015 Sep; 6(29):27146-59. PubMed ID: 26450645
[TBL] [Abstract][Full Text] [Related]
50. KRAS and cancer stem cells in APC-mutant colorectal cancer.
Fearon ER; Wicha MS
J Natl Cancer Inst; 2014 Feb; 106(2):djt444. PubMed ID: 24491303
[No Abstract] [Full Text] [Related]
51. Wnt/beta-catenin pathway deregulation in childhood adrenocortical tumors.
Leal LF; Mermejo LM; Ramalho LZ; Martinelli CE; Yunes JA; Seidinger AL; Mastellaro MJ; Cardinalli IA; Brandalise SR; Moreira AC; Tone LG; Scrideli CA; Castro M; Antonini SR
J Clin Endocrinol Metab; 2011 Oct; 96(10):3106-14. PubMed ID: 21849527
[TBL] [Abstract][Full Text] [Related]
52. How a growth control path takes a wrong turn to cancer.
Pennisi E
Science; 1998 Sep; 281(5382):1438-9, 1441. PubMed ID: 9750112
[No Abstract] [Full Text] [Related]
53. KY1022, a small molecule destabilizing Ras via targeting the Wnt/β-catenin pathway, inhibits development of metastatic colorectal cancer.
Cho YH; Cha PH; Kaduwal S; Park JC; Lee SK; Yoon JS; Shin W; Kim H; Ro EJ; Koo KH; Park KS; Han G; Choi KY
Oncotarget; 2016 Dec; 7(49):81727-81740. PubMed ID: 27835580
[TBL] [Abstract][Full Text] [Related]
54. Functional interaction of DNA topoisomerase IIalpha with the beta-catenin and T-cell factor-4 complex.
Huang L; Shitashige M; Satow R; Honda K; Ono M; Yun J; Tomida A; Tsuruo T; Hirohashi S; Yamada T
Gastroenterology; 2007 Nov; 133(5):1569-78. PubMed ID: 17983804
[TBL] [Abstract][Full Text] [Related]
55. Hypermethylation of APC promoter 1A is associated with moderate activation of Wnt signalling pathway in a subset of colorectal serrated adenomas.
Fu X; Li J; Li K; Tian X; Zhang Y
Histopathology; 2009 Nov; 55(5):554-63. PubMed ID: 19912361
[TBL] [Abstract][Full Text] [Related]
56. The SIAH E3 ubiquitin ligases promote Wnt/β-catenin signaling through mediating Wnt-induced Axin degradation.
Ji L; Jiang B; Jiang X; Charlat O; Chen A; Mickanin C; Bauer A; Xu W; Yan X; Cong F
Genes Dev; 2017 May; 31(9):904-915. PubMed ID: 28546513
[TBL] [Abstract][Full Text] [Related]
57. Expression level of Wnt signaling components possibly influences the biological behavior of colorectal cancer in different age groups.
Seidler HB; Utsuyama M; Nagaoka S; Takemura T; Kitagawa M; Hirokawa K
Exp Mol Pathol; 2004 Jun; 76(3):224-33. PubMed ID: 15126105
[TBL] [Abstract][Full Text] [Related]
58. BCL9-2 promotes early stages of intestinal tumor progression.
Brembeck FH; Wiese M; Zatula N; Grigoryan T; Dai Y; Fritzmann J; Birchmeier W
Gastroenterology; 2011 Oct; 141(4):1359-70, 1370.e1-3. PubMed ID: 21703997
[TBL] [Abstract][Full Text] [Related]
59. ShRNA-mediated gene silencing of beta-catenin inhibits growth of human colon cancer cells.
Huang WS; Wang JP; Wang T; Fang JY; Lan P; Ma JP
World J Gastroenterol; 2007 Dec; 13(48):6581-7. PubMed ID: 18161931
[TBL] [Abstract][Full Text] [Related]
60. Simultaneous destabilization of β-catenin and Ras via targeting of the axin-RGS domain as a potential therapeutic strategy for colorectal cancer.
Cha PH; Choi KY
BMB Rep; 2016 Sep; 49(9):455-6. PubMed ID: 27470214
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
